nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—HTR7—coronary artery disease	0.113	0.424	CbGaD
Aripiprazole—ADRB1—coronary artery disease	0.0968	0.363	CbGaD
Aripiprazole—HTR2A—coronary artery disease	0.0568	0.213	CbGaD
Aripiprazole—HTR1B—Penbutolol—coronary artery disease	0.0319	0.0841	CbGbCtD
Aripiprazole—ADRB1—Penbutolol—coronary artery disease	0.025	0.0658	CbGbCtD
Aripiprazole—HTR1A—Penbutolol—coronary artery disease	0.02	0.0527	CbGbCtD
Aripiprazole—ADRB1—Timolol—coronary artery disease	0.0176	0.0463	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.0129	0.0339	CbGbCtD
Aripiprazole—CYP3A7—Eplerenone—coronary artery disease	0.0129	0.0339	CbGbCtD
Aripiprazole—ABCB1—Ticagrelor—coronary artery disease	0.0109	0.0288	CbGbCtD
Aripiprazole—CYP3A5—Clopidogrel—coronary artery disease	0.0104	0.0273	CbGbCtD
Aripiprazole—CYP3A5—Eplerenone—coronary artery disease	0.00965	0.0254	CbGbCtD
Aripiprazole—CYP3A7—Simvastatin—coronary artery disease	0.00829	0.0218	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00829	0.0218	CbGbCtD
Aripiprazole—CYP3A7—Lovastatin—coronary artery disease	0.00811	0.0213	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00811	0.0213	CbGbCtD
Aripiprazole—KCNH2—purkinje fiber—coronary artery disease	0.00745	0.154	CbGeAlD
Aripiprazole—CYP3A7—Atorvastatin—coronary artery disease	0.00739	0.0194	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00739	0.0194	CbGbCtD
Aripiprazole—ABCB1—Clopidogrel—coronary artery disease	0.00676	0.0178	CbGbCtD
Aripiprazole—ABCB1—Perindopril—coronary artery disease	0.00676	0.0178	CbGbCtD
Aripiprazole—CYP3A5—Rosuvastatin—coronary artery disease	0.00669	0.0176	CbGbCtD
Aripiprazole—CYP3A4—Ticagrelor—coronary artery disease	0.00655	0.0172	CbGbCtD
Aripiprazole—CYP3A5—Simvastatin—coronary artery disease	0.00622	0.0164	CbGbCtD
Aripiprazole—CYP3A5—Lovastatin—coronary artery disease	0.00609	0.016	CbGbCtD
Aripiprazole—CYP3A5—Pravastatin—coronary artery disease	0.00609	0.016	CbGbCtD
Aripiprazole—ABCB1—Pitavastatin—coronary artery disease	0.0059	0.0155	CbGbCtD
Aripiprazole—ABCB1—Telmisartan—coronary artery disease	0.0059	0.0155	CbGbCtD
Aripiprazole—CYP3A4—Fenofibrate—coronary artery disease	0.00584	0.0154	CbGbCtD
Aripiprazole—ABCB1—Enalapril—coronary artery disease	0.0056	0.0147	CbGbCtD
Aripiprazole—ABCB1—Lisinopril—coronary artery disease	0.0056	0.0147	CbGbCtD
Aripiprazole—CYP3A5—Atorvastatin—coronary artery disease	0.00554	0.0146	CbGbCtD
Aripiprazole—CYP3A5—Losartan—coronary artery disease	0.00507	0.0133	CbGbCtD
Aripiprazole—CYP2D6—Niacin—coronary artery disease	0.00482	0.0127	CbGbCtD
Aripiprazole—HTR2B—cardial valve—coronary artery disease	0.00481	0.0996	CbGeAlD
Aripiprazole—ABCB1—Timolol—coronary artery disease	0.00476	0.0125	CbGbCtD
Aripiprazole—CYP3A4—Gemfibrozil—coronary artery disease	0.00467	0.0123	CbGbCtD
Aripiprazole—CYP2D6—Timolol—coronary artery disease	0.00448	0.0118	CbGbCtD
Aripiprazole—ABCB1—Ezetimibe—coronary artery disease	0.00435	0.0115	CbGbCtD
Aripiprazole—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00424	0.0112	CbGbCtD
Aripiprazole—ABCB1—Captopril—coronary artery disease	0.00419	0.011	CbGbCtD
Aripiprazole—CYP3A4—Clopidogrel—coronary artery disease	0.00405	0.0107	CbGbCtD
Aripiprazole—ABCB1—Simvastatin—coronary artery disease	0.00405	0.0106	CbGbCtD
Aripiprazole—ABCB1—Lovastatin—coronary artery disease	0.00396	0.0104	CbGbCtD
Aripiprazole—ABCB1—Pravastatin—coronary artery disease	0.00396	0.0104	CbGbCtD
Aripiprazole—CYP2D6—Captopril—coronary artery disease	0.00395	0.0104	CbGbCtD
Aripiprazole—KCNH2—endocardium—coronary artery disease	0.00384	0.0795	CbGeAlD
Aripiprazole—CYP2D6—Simvastatin—coronary artery disease	0.00381	0.01	CbGbCtD
Aripiprazole—CYP3A4—Eplerenone—coronary artery disease	0.00376	0.0099	CbGbCtD
Aripiprazole—CYP2D6—Lovastatin—coronary artery disease	0.00373	0.00982	CbGbCtD
Aripiprazole—CYP2D6—Pravastatin—coronary artery disease	0.00373	0.00982	CbGbCtD
Aripiprazole—ABCB1—Atorvastatin—coronary artery disease	0.00361	0.00949	CbGbCtD
Aripiprazole—CYP2D6—Atorvastatin—coronary artery disease	0.0034	0.00894	CbGbCtD
Aripiprazole—CYP3A4—Enalapril—coronary artery disease	0.00335	0.00883	CbGbCtD
Aripiprazole—ABCB1—Losartan—coronary artery disease	0.0033	0.00868	CbGbCtD
Aripiprazole—CYP3A4—Rosuvastatin—coronary artery disease	0.00261	0.00686	CbGbCtD
Aripiprazole—CYP3A4—Ezetimibe—coronary artery disease	0.00261	0.00686	CbGbCtD
Aripiprazole—HTR3A—vagus nerve—coronary artery disease	0.00243	0.0503	CbGeAlD
Aripiprazole—CYP3A4—Simvastatin—coronary artery disease	0.00242	0.00638	CbGbCtD
Aripiprazole—CYP3A4—Lovastatin—coronary artery disease	0.00237	0.00624	CbGbCtD
Aripiprazole—CYP3A4—Pravastatin—coronary artery disease	0.00237	0.00624	CbGbCtD
Aripiprazole—CYP3A4—Atorvastatin—coronary artery disease	0.00216	0.00569	CbGbCtD
Aripiprazole—CYP3A4—Losartan—coronary artery disease	0.00198	0.0052	CbGbCtD
Aripiprazole—HTR7—pulmonary artery—coronary artery disease	0.00167	0.0345	CbGeAlD
Aripiprazole—Cilostazol—PDE3A—coronary artery disease	0.00164	0.579	CrCbGaD
Aripiprazole—HTR7—sympathetic nervous system—coronary artery disease	0.00162	0.0336	CbGeAlD
Aripiprazole—HTR2A—arteriole—coronary artery disease	0.00159	0.0329	CbGeAlD
Aripiprazole—HTR7—vagus nerve—coronary artery disease	0.00157	0.0325	CbGeAlD
Aripiprazole—HTR7—vein—coronary artery disease	0.00152	0.0314	CbGeAlD
Aripiprazole—HTR7—autonomic nervous system—coronary artery disease	0.00109	0.0226	CbGeAlD
Aripiprazole—HTR2A—pulmonary artery—coronary artery disease	0.00104	0.0215	CbGeAlD
Aripiprazole—HTR2A—sympathetic nervous system—coronary artery disease	0.00101	0.0209	CbGeAlD
Aripiprazole—HTR2A—vagus nerve—coronary artery disease	0.000979	0.0203	CbGeAlD
Aripiprazole—HTR2A—vein—coronary artery disease	0.000946	0.0196	CbGeAlD
Aripiprazole—HTR1B—artery—coronary artery disease	0.000802	0.0166	CbGeAlD
Aripiprazole—HTR1D—artery—coronary artery disease	0.000776	0.0161	CbGeAlD
Aripiprazole—DRD4—heart—coronary artery disease	0.000724	0.015	CbGeAlD
Aripiprazole—HTR2A—autonomic nervous system—coronary artery disease	0.00068	0.0141	CbGeAlD
Aripiprazole—HTR7—artery—coronary artery disease	0.000618	0.0128	CbGeAlD
Aripiprazole—H1F0—cardiac ventricle—coronary artery disease	0.000562	0.0116	CbGeAlD
Aripiprazole—H1F0—myocardium—coronary artery disease	0.000529	0.0109	CbGeAlD
Aripiprazole—HTR7—endothelium—coronary artery disease	0.000522	0.0108	CbGeAlD
Aripiprazole—Cilostazol—CYP2C19—coronary artery disease	0.000434	0.153	CrCbGaD
Aripiprazole—ADRB1—cardiac ventricle—coronary artery disease	0.000423	0.00876	CbGeAlD
Aripiprazole—ADRB1—myocardium—coronary artery disease	0.000398	0.00824	CbGeAlD
Aripiprazole—HTR2A—artery—coronary artery disease	0.000385	0.00798	CbGeAlD
Aripiprazole—H1F0—heart—coronary artery disease	0.000369	0.00764	CbGeAlD
Aripiprazole—H1F0—cardiovascular system—coronary artery disease	0.000348	0.00721	CbGeAlD
Aripiprazole—HTR2A—endothelium—coronary artery disease	0.000326	0.00674	CbGeAlD
Aripiprazole—KCNH2—cardiac ventricle—coronary artery disease	0.000323	0.00669	CbGeAlD
Aripiprazole—ADRA2C—cardiac ventricle—coronary artery disease	0.000319	0.0066	CbGeAlD
Aripiprazole—H1F0—cardiac atrium—coronary artery disease	0.000316	0.00653	CbGeAlD
Aripiprazole—KCNH2—myocardium—coronary artery disease	0.000304	0.00629	CbGeAlD
Aripiprazole—ADRA2C—myocardium—coronary artery disease	0.0003	0.00621	CbGeAlD
Aripiprazole—CHRM2—heart—coronary artery disease	0.000294	0.00608	CbGeAlD
Aripiprazole—HTR1B—cardiovascular system—coronary artery disease	0.000279	0.00577	CbGeAlD
Aripiprazole—ADRB1—heart—coronary artery disease	0.000278	0.00575	CbGeAlD
Aripiprazole—CHRM2—cardiovascular system—coronary artery disease	0.000277	0.00574	CbGeAlD
Aripiprazole—H1F0—blood—coronary artery disease	0.000275	0.0057	CbGeAlD
Aripiprazole—HTR1D—cardiovascular system—coronary artery disease	0.00027	0.00558	CbGeAlD
Aripiprazole—HTR2B—heart—coronary artery disease	0.000266	0.0055	CbGeAlD
Aripiprazole—HTR3A—blood—coronary artery disease	0.000263	0.00544	CbGeAlD
Aripiprazole—ADRB1—cardiovascular system—coronary artery disease	0.000262	0.00543	CbGeAlD
Aripiprazole—CHRM1—cardiovascular system—coronary artery disease	0.000252	0.00522	CbGeAlD
Aripiprazole—HTR2B—cardiovascular system—coronary artery disease	0.000251	0.00519	CbGeAlD
Aripiprazole—ADRB1—cardiac atrium—coronary artery disease	0.000238	0.00492	CbGeAlD
Aripiprazole—HTR7—heart—coronary artery disease	0.000228	0.00471	CbGeAlD
Aripiprazole—Ziprasidone—HTR7—coronary artery disease	0.000225	0.0795	CrCbGaD
Aripiprazole—HTR1A—cardiovascular system—coronary artery disease	0.000225	0.00465	CbGeAlD
Aripiprazole—ADRA1A—heart—coronary artery disease	0.00022	0.00455	CbGeAlD
Aripiprazole—HTR7—cardiovascular system—coronary artery disease	0.000215	0.00445	CbGeAlD
Aripiprazole—KCNH2—heart—coronary artery disease	0.000212	0.00439	CbGeAlD
Aripiprazole—ADRA2C—heart—coronary artery disease	0.000209	0.00433	CbGeAlD
Aripiprazole—ADRA1A—cardiovascular system—coronary artery disease	0.000207	0.00429	CbGeAlD
Aripiprazole—SLC6A4—blood—coronary artery disease	0.0002	0.00415	CbGeAlD
Aripiprazole—KCNH2—cardiovascular system—coronary artery disease	0.0002	0.00414	CbGeAlD
Aripiprazole—HTR2B—blood—coronary artery disease	0.000198	0.00411	CbGeAlD
Aripiprazole—KCNH2—cardiac atrium—coronary artery disease	0.000181	0.00376	CbGeAlD
Aripiprazole—ADRA2C—cardiac atrium—coronary artery disease	0.000179	0.00371	CbGeAlD
Aripiprazole—HTR7—blood—coronary artery disease	0.00017	0.00352	CbGeAlD
Aripiprazole—ADRA2A—heart—coronary artery disease	0.000167	0.00346	CbGeAlD
Aripiprazole—ADRA1A—blood—coronary artery disease	0.000164	0.00339	CbGeAlD
Aripiprazole—KCNH2—blood—coronary artery disease	0.000158	0.00328	CbGeAlD
Aripiprazole—ADRA2C—blood—coronary artery disease	0.000156	0.00323	CbGeAlD
Aripiprazole—ADRA2A—cardiac atrium—coronary artery disease	0.000143	0.00296	CbGeAlD
Aripiprazole—HTR2A—heart—coronary artery disease	0.000142	0.00294	CbGeAlD
Aripiprazole—HTR2A—cardiovascular system—coronary artery disease	0.000134	0.00277	CbGeAlD
Aripiprazole—CYP3A5—blood—coronary artery disease	0.000131	0.00271	CbGeAlD
Aripiprazole—ADRA2A—blood—coronary artery disease	0.000125	0.00258	CbGeAlD
Aripiprazole—Ziprasidone—HTR2A—coronary artery disease	0.000113	0.04	CrCbGaD
Aripiprazole—Perphenazine—HTR7—coronary artery disease	0.000112	0.0396	CrCbGaD
Aripiprazole—HTR2A—blood—coronary artery disease	0.000106	0.00219	CbGeAlD
Aripiprazole—CYP3A4—blood—coronary artery disease	9.81e-05	0.00203	CbGeAlD
Aripiprazole—CYP2D6—blood—coronary artery disease	9.65e-05	0.002	CbGeAlD
Aripiprazole—Nefazodone—HTR2A—coronary artery disease	9.51e-05	0.0336	CrCbGaD
Aripiprazole—ABCB1—heart—coronary artery disease	9.3e-05	0.00193	CbGeAlD
Aripiprazole—Trazodone—HTR2A—coronary artery disease	8.8e-05	0.0311	CrCbGaD
Aripiprazole—ABCB1—cardiovascular system—coronary artery disease	8.78e-05	0.00182	CbGeAlD
Aripiprazole—Perphenazine—CYP2C19—coronary artery disease	6.95e-05	0.0246	CrCbGaD
Aripiprazole—ABCB1—blood—coronary artery disease	6.94e-05	0.00144	CbGeAlD
Aripiprazole—Perphenazine—HTR2A—coronary artery disease	5.64e-05	0.0199	CrCbGaD
Aripiprazole—Malaise—Lisinopril—coronary artery disease	2.01e-05	0.000111	CcSEcCtD
Aripiprazole—Anaphylactic shock—Ramipril—coronary artery disease	2.01e-05	0.000111	CcSEcCtD
Aripiprazole—Oedema—Ramipril—coronary artery disease	2.01e-05	0.000111	CcSEcCtD
Aripiprazole—Vertigo—Lisinopril—coronary artery disease	2e-05	0.00011	CcSEcCtD
Aripiprazole—Dry mouth—Timolol—coronary artery disease	2e-05	0.00011	CcSEcCtD
Aripiprazole—Pain—Losartan—coronary artery disease	2e-05	0.00011	CcSEcCtD
Aripiprazole—Constipation—Losartan—coronary artery disease	2e-05	0.00011	CcSEcCtD
Aripiprazole—Syncope—Lisinopril—coronary artery disease	2e-05	0.00011	CcSEcCtD
Aripiprazole—Vomiting—Eplerenone—coronary artery disease	2e-05	0.00011	CcSEcCtD
Aripiprazole—Feeling abnormal—Furosemide—coronary artery disease	2e-05	0.00011	CcSEcCtD
Aripiprazole—Leukopenia—Lisinopril—coronary artery disease	2e-05	0.00011	CcSEcCtD
Aripiprazole—Nausea—Fenofibrate—coronary artery disease	1.99e-05	0.00011	CcSEcCtD
Aripiprazole—Pruritus—Niacin—coronary artery disease	1.99e-05	0.00011	CcSEcCtD
Aripiprazole—Asthenia—Pravastatin—coronary artery disease	1.99e-05	0.00011	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Furosemide—coronary artery disease	1.98e-05	0.000109	CcSEcCtD
Aripiprazole—Rash—Eplerenone—coronary artery disease	1.98e-05	0.000109	CcSEcCtD
Aripiprazole—Urticaria—Perindopril—coronary artery disease	1.98e-05	0.000109	CcSEcCtD
Aripiprazole—Hypersensitivity—Trandolapril—coronary artery disease	1.98e-05	0.000109	CcSEcCtD
Aripiprazole—Dermatitis—Eplerenone—coronary artery disease	1.98e-05	0.000109	CcSEcCtD
Aripiprazole—Diarrhoea—Valsartan—coronary artery disease	1.98e-05	0.000109	CcSEcCtD
Aripiprazole—Confusional state—Timolol—coronary artery disease	1.98e-05	0.000109	CcSEcCtD
Aripiprazole—Shock—Ramipril—coronary artery disease	1.97e-05	0.000109	CcSEcCtD
Aripiprazole—Hypersensitivity—Enalapril—coronary artery disease	1.97e-05	0.000109	CcSEcCtD
Aripiprazole—Abdominal pain—Perindopril—coronary artery disease	1.97e-05	0.000109	CcSEcCtD
Aripiprazole—Body temperature increased—Perindopril—coronary artery disease	1.97e-05	0.000109	CcSEcCtD
Aripiprazole—Palpitations—Lisinopril—coronary artery disease	1.97e-05	0.000109	CcSEcCtD
Aripiprazole—Diarrhoea—Olmesartan—coronary artery disease	1.97e-05	0.000109	CcSEcCtD
Aripiprazole—Headache—Eplerenone—coronary artery disease	1.97e-05	0.000109	CcSEcCtD
Aripiprazole—Nervous system disorder—Ramipril—coronary artery disease	1.97e-05	0.000108	CcSEcCtD
Aripiprazole—Thrombocytopenia—Ramipril—coronary artery disease	1.96e-05	0.000108	CcSEcCtD
Aripiprazole—Oedema—Timolol—coronary artery disease	1.96e-05	0.000108	CcSEcCtD
Aripiprazole—Anaphylactic shock—Timolol—coronary artery disease	1.96e-05	0.000108	CcSEcCtD
Aripiprazole—Pruritus—Pravastatin—coronary artery disease	1.96e-05	0.000108	CcSEcCtD
Aripiprazole—Loss of consciousness—Lisinopril—coronary artery disease	1.96e-05	0.000108	CcSEcCtD
Aripiprazole—Nausea—Clopidogrel—coronary artery disease	1.96e-05	0.000108	CcSEcCtD
Aripiprazole—Tachycardia—Ramipril—coronary artery disease	1.96e-05	0.000108	CcSEcCtD
Aripiprazole—Skin disorder—Ramipril—coronary artery disease	1.95e-05	0.000107	CcSEcCtD
Aripiprazole—Infection—Timolol—coronary artery disease	1.95e-05	0.000107	CcSEcCtD
Aripiprazole—Vomiting—Simvastatin—coronary artery disease	1.95e-05	0.000107	CcSEcCtD
Aripiprazole—Hypersensitivity—Telmisartan—coronary artery disease	1.95e-05	0.000107	CcSEcCtD
Aripiprazole—Cough—Lisinopril—coronary artery disease	1.95e-05	0.000107	CcSEcCtD
Aripiprazole—Nausea—Lovastatin—coronary artery disease	1.95e-05	0.000107	CcSEcCtD
Aripiprazole—Hyperhidrosis—Ramipril—coronary artery disease	1.94e-05	0.000107	CcSEcCtD
Aripiprazole—Rash—Simvastatin—coronary artery disease	1.93e-05	0.000106	CcSEcCtD
Aripiprazole—Dermatitis—Simvastatin—coronary artery disease	1.93e-05	0.000106	CcSEcCtD
Aripiprazole—Asthenia—Trandolapril—coronary artery disease	1.93e-05	0.000106	CcSEcCtD
Aripiprazole—Shock—Timolol—coronary artery disease	1.93e-05	0.000106	CcSEcCtD
Aripiprazole—Feeling abnormal—Losartan—coronary artery disease	1.93e-05	0.000106	CcSEcCtD
Aripiprazole—Urticaria—Furosemide—coronary artery disease	1.93e-05	0.000106	CcSEcCtD
Aripiprazole—Diarrhoea—Niacin—coronary artery disease	1.93e-05	0.000106	CcSEcCtD
Aripiprazole—Nervous system disorder—Timolol—coronary artery disease	1.92e-05	0.000106	CcSEcCtD
Aripiprazole—Asthenia—Enalapril—coronary artery disease	1.92e-05	0.000106	CcSEcCtD
Aripiprazole—Headache—Simvastatin—coronary artery disease	1.92e-05	0.000106	CcSEcCtD
Aripiprazole—Abdominal pain—Furosemide—coronary artery disease	1.92e-05	0.000106	CcSEcCtD
Aripiprazole—Body temperature increased—Furosemide—coronary artery disease	1.92e-05	0.000106	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Losartan—coronary artery disease	1.91e-05	0.000105	CcSEcCtD
Aripiprazole—Dizziness—Valsartan—coronary artery disease	1.91e-05	0.000105	CcSEcCtD
Aripiprazole—Anorexia—Ramipril—coronary artery disease	1.91e-05	0.000105	CcSEcCtD
Aripiprazole—Nausea—Ezetimibe—coronary artery disease	1.91e-05	0.000105	CcSEcCtD
Aripiprazole—Skin disorder—Timolol—coronary artery disease	1.91e-05	0.000105	CcSEcCtD
Aripiprazole—Dizziness—Olmesartan—coronary artery disease	1.9e-05	0.000105	CcSEcCtD
Aripiprazole—Pruritus—Trandolapril—coronary artery disease	1.9e-05	0.000105	CcSEcCtD
Aripiprazole—Myalgia—Lisinopril—coronary artery disease	1.9e-05	0.000105	CcSEcCtD
Aripiprazole—Chest pain—Lisinopril—coronary artery disease	1.9e-05	0.000105	CcSEcCtD
Aripiprazole—Arthralgia—Lisinopril—coronary artery disease	1.9e-05	0.000105	CcSEcCtD
Aripiprazole—Hyperhidrosis—Timolol—coronary artery disease	1.9e-05	0.000104	CcSEcCtD
Aripiprazole—Asthenia—Telmisartan—coronary artery disease	1.9e-05	0.000104	CcSEcCtD
Aripiprazole—Pruritus—Enalapril—coronary artery disease	1.9e-05	0.000104	CcSEcCtD
Aripiprazole—Diarrhoea—Pravastatin—coronary artery disease	1.9e-05	0.000104	CcSEcCtD
Aripiprazole—Anxiety—Lisinopril—coronary artery disease	1.89e-05	0.000104	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	1.89e-05	0.000104	CcSEcCtD
Aripiprazole—Discomfort—Lisinopril—coronary artery disease	1.88e-05	0.000103	CcSEcCtD
Aripiprazole—Hypotension—Ramipril—coronary artery disease	1.88e-05	0.000103	CcSEcCtD
Aripiprazole—Anorexia—Timolol—coronary artery disease	1.87e-05	0.000103	CcSEcCtD
Aripiprazole—Pruritus—Telmisartan—coronary artery disease	1.87e-05	0.000103	CcSEcCtD
Aripiprazole—Nausea—Eplerenone—coronary artery disease	1.87e-05	0.000103	CcSEcCtD
Aripiprazole—Dizziness—Niacin—coronary artery disease	1.86e-05	0.000103	CcSEcCtD
Aripiprazole—Urticaria—Losartan—coronary artery disease	1.86e-05	0.000102	CcSEcCtD
Aripiprazole—Dry mouth—Lisinopril—coronary artery disease	1.86e-05	0.000102	CcSEcCtD
Aripiprazole—Abdominal pain—Losartan—coronary artery disease	1.85e-05	0.000102	CcSEcCtD
Aripiprazole—Body temperature increased—Losartan—coronary artery disease	1.85e-05	0.000102	CcSEcCtD
Aripiprazole—Asthenia—Captopril—coronary artery disease	1.84e-05	0.000102	CcSEcCtD
Aripiprazole—Diarrhoea—Trandolapril—coronary artery disease	1.84e-05	0.000101	CcSEcCtD
Aripiprazole—Vomiting—Valsartan—coronary artery disease	1.84e-05	0.000101	CcSEcCtD
Aripiprazole—Confusional state—Lisinopril—coronary artery disease	1.84e-05	0.000101	CcSEcCtD
Aripiprazole—Diarrhoea—Enalapril—coronary artery disease	1.83e-05	0.000101	CcSEcCtD
Aripiprazole—Hypotension—Timolol—coronary artery disease	1.83e-05	0.000101	CcSEcCtD
Aripiprazole—Dizziness—Pravastatin—coronary artery disease	1.83e-05	0.000101	CcSEcCtD
Aripiprazole—Vomiting—Olmesartan—coronary artery disease	1.83e-05	0.000101	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Ramipril—coronary artery disease	1.83e-05	0.000101	CcSEcCtD
Aripiprazole—Rash—Valsartan—coronary artery disease	1.82e-05	0.000101	CcSEcCtD
Aripiprazole—Dermatitis—Valsartan—coronary artery disease	1.82e-05	0.0001	CcSEcCtD
Aripiprazole—Nausea—Simvastatin—coronary artery disease	1.82e-05	0.0001	CcSEcCtD
Aripiprazole—Anaphylactic shock—Lisinopril—coronary artery disease	1.82e-05	0.0001	CcSEcCtD
Aripiprazole—Oedema—Lisinopril—coronary artery disease	1.82e-05	0.0001	CcSEcCtD
Aripiprazole—Pruritus—Captopril—coronary artery disease	1.82e-05	0.0001	CcSEcCtD
Aripiprazole—Rash—Olmesartan—coronary artery disease	1.82e-05	0.0001	CcSEcCtD
Aripiprazole—Insomnia—Ramipril—coronary artery disease	1.82e-05	0.0001	CcSEcCtD
Aripiprazole—Dermatitis—Olmesartan—coronary artery disease	1.81e-05	9.99e-05	CcSEcCtD
Aripiprazole—Headache—Valsartan—coronary artery disease	1.81e-05	9.99e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Telmisartan—coronary artery disease	1.81e-05	9.96e-05	CcSEcCtD
Aripiprazole—Infection—Lisinopril—coronary artery disease	1.81e-05	9.96e-05	CcSEcCtD
Aripiprazole—Headache—Olmesartan—coronary artery disease	1.8e-05	9.94e-05	CcSEcCtD
Aripiprazole—Paraesthesia—Ramipril—coronary artery disease	1.8e-05	9.93e-05	CcSEcCtD
Aripiprazole—Shock—Lisinopril—coronary artery disease	1.79e-05	9.86e-05	CcSEcCtD
Aripiprazole—Asthenia—Perindopril—coronary artery disease	1.79e-05	9.86e-05	CcSEcCtD
Aripiprazole—Dyspnoea—Ramipril—coronary artery disease	1.79e-05	9.86e-05	CcSEcCtD
Aripiprazole—Vomiting—Niacin—coronary artery disease	1.79e-05	9.86e-05	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Timolol—coronary artery disease	1.79e-05	9.85e-05	CcSEcCtD
Aripiprazole—Hypersensitivity—Furosemide—coronary artery disease	1.79e-05	9.85e-05	CcSEcCtD
Aripiprazole—Somnolence—Ramipril—coronary artery disease	1.78e-05	9.83e-05	CcSEcCtD
Aripiprazole—Thrombocytopenia—Lisinopril—coronary artery disease	1.78e-05	9.82e-05	CcSEcCtD
Aripiprazole—Dizziness—Trandolapril—coronary artery disease	1.78e-05	9.8e-05	CcSEcCtD
Aripiprazole—Tachycardia—Lisinopril—coronary artery disease	1.78e-05	9.79e-05	CcSEcCtD
Aripiprazole—Insomnia—Timolol—coronary artery disease	1.77e-05	9.78e-05	CcSEcCtD
Aripiprazole—Rash—Niacin—coronary artery disease	1.77e-05	9.77e-05	CcSEcCtD
Aripiprazole—Dermatitis—Niacin—coronary artery disease	1.77e-05	9.76e-05	CcSEcCtD
Aripiprazole—Dizziness—Enalapril—coronary artery disease	1.77e-05	9.76e-05	CcSEcCtD
Aripiprazole—Skin disorder—Lisinopril—coronary artery disease	1.77e-05	9.74e-05	CcSEcCtD
Aripiprazole—Dyspepsia—Ramipril—coronary artery disease	1.77e-05	9.73e-05	CcSEcCtD
Aripiprazole—Pruritus—Perindopril—coronary artery disease	1.77e-05	9.73e-05	CcSEcCtD
Aripiprazole—Headache—Niacin—coronary artery disease	1.76e-05	9.71e-05	CcSEcCtD
Aripiprazole—Paraesthesia—Timolol—coronary artery disease	1.76e-05	9.71e-05	CcSEcCtD
Aripiprazole—Vomiting—Pravastatin—coronary artery disease	1.76e-05	9.7e-05	CcSEcCtD
Aripiprazole—Hyperhidrosis—Lisinopril—coronary artery disease	1.76e-05	9.69e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Captopril—coronary artery disease	1.76e-05	9.69e-05	CcSEcCtD
Aripiprazole—Dyspnoea—Timolol—coronary artery disease	1.75e-05	9.64e-05	CcSEcCtD
Aripiprazole—Dizziness—Telmisartan—coronary artery disease	1.75e-05	9.63e-05	CcSEcCtD
Aripiprazole—Rash—Pravastatin—coronary artery disease	1.75e-05	9.62e-05	CcSEcCtD
Aripiprazole—Dermatitis—Pravastatin—coronary artery disease	1.75e-05	9.61e-05	CcSEcCtD
Aripiprazole—Decreased appetite—Ramipril—coronary artery disease	1.74e-05	9.61e-05	CcSEcCtD
Aripiprazole—Somnolence—Timolol—coronary artery disease	1.74e-05	9.61e-05	CcSEcCtD
Aripiprazole—Asthenia—Furosemide—coronary artery disease	1.74e-05	9.59e-05	CcSEcCtD
Aripiprazole—Headache—Pravastatin—coronary artery disease	1.74e-05	9.56e-05	CcSEcCtD
Aripiprazole—Anorexia—Lisinopril—coronary artery disease	1.73e-05	9.56e-05	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Ramipril—coronary artery disease	1.73e-05	9.54e-05	CcSEcCtD
Aripiprazole—Fatigue—Ramipril—coronary artery disease	1.73e-05	9.53e-05	CcSEcCtD
Aripiprazole—Dyspepsia—Timolol—coronary artery disease	1.73e-05	9.51e-05	CcSEcCtD
Aripiprazole—Hypersensitivity—Losartan—coronary artery disease	1.72e-05	9.5e-05	CcSEcCtD
Aripiprazole—Nausea—Valsartan—coronary artery disease	1.72e-05	9.47e-05	CcSEcCtD
Aripiprazole—Pruritus—Furosemide—coronary artery disease	1.72e-05	9.45e-05	CcSEcCtD
Aripiprazole—Constipation—Ramipril—coronary artery disease	1.72e-05	9.45e-05	CcSEcCtD
Aripiprazole—Nausea—Olmesartan—coronary artery disease	1.71e-05	9.42e-05	CcSEcCtD
Aripiprazole—Vomiting—Trandolapril—coronary artery disease	1.71e-05	9.42e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Perindopril—coronary artery disease	1.71e-05	9.41e-05	CcSEcCtD
Aripiprazole—Decreased appetite—Timolol—coronary artery disease	1.71e-05	9.4e-05	CcSEcCtD
Aripiprazole—Vomiting—Enalapril—coronary artery disease	1.7e-05	9.39e-05	CcSEcCtD
Aripiprazole—Hypotension—Lisinopril—coronary artery disease	1.7e-05	9.37e-05	CcSEcCtD
Aripiprazole—Dizziness—Captopril—coronary artery disease	1.7e-05	9.36e-05	CcSEcCtD
Aripiprazole—Rash—Trandolapril—coronary artery disease	1.7e-05	9.34e-05	CcSEcCtD
Aripiprazole—Dermatitis—Trandolapril—coronary artery disease	1.69e-05	9.34e-05	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Timolol—coronary artery disease	1.69e-05	9.33e-05	CcSEcCtD
Aripiprazole—Fatigue—Timolol—coronary artery disease	1.69e-05	9.32e-05	CcSEcCtD
Aripiprazole—Rash—Enalapril—coronary artery disease	1.69e-05	9.31e-05	CcSEcCtD
Aripiprazole—Dermatitis—Enalapril—coronary artery disease	1.69e-05	9.3e-05	CcSEcCtD
Aripiprazole—Headache—Trandolapril—coronary artery disease	1.69e-05	9.28e-05	CcSEcCtD
Aripiprazole—Vomiting—Telmisartan—coronary artery disease	1.68e-05	9.26e-05	CcSEcCtD
Aripiprazole—Asthenia—Losartan—coronary artery disease	1.68e-05	9.25e-05	CcSEcCtD
Aripiprazole—Headache—Enalapril—coronary artery disease	1.68e-05	9.25e-05	CcSEcCtD
Aripiprazole—Pain—Timolol—coronary artery disease	1.68e-05	9.24e-05	CcSEcCtD
Aripiprazole—Nausea—Niacin—coronary artery disease	1.67e-05	9.21e-05	CcSEcCtD
Aripiprazole—Rash—Telmisartan—coronary artery disease	1.67e-05	9.18e-05	CcSEcCtD
Aripiprazole—Dermatitis—Telmisartan—coronary artery disease	1.66e-05	9.17e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Furosemide—coronary artery disease	1.66e-05	9.14e-05	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.66e-05	9.13e-05	CcSEcCtD
Aripiprazole—Pruritus—Losartan—coronary artery disease	1.66e-05	9.12e-05	CcSEcCtD
Aripiprazole—Headache—Telmisartan—coronary artery disease	1.66e-05	9.12e-05	CcSEcCtD
Aripiprazole—Feeling abnormal—Ramipril—coronary artery disease	1.65e-05	9.11e-05	CcSEcCtD
Aripiprazole—Dizziness—Perindopril—coronary artery disease	1.65e-05	9.09e-05	CcSEcCtD
Aripiprazole—Insomnia—Lisinopril—coronary artery disease	1.65e-05	9.07e-05	CcSEcCtD
Aripiprazole—Nausea—Pravastatin—coronary artery disease	1.65e-05	9.07e-05	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Ramipril—coronary artery disease	1.64e-05	9.04e-05	CcSEcCtD
Aripiprazole—Paraesthesia—Lisinopril—coronary artery disease	1.63e-05	9e-05	CcSEcCtD
Aripiprazole—Vomiting—Captopril—coronary artery disease	1.63e-05	9e-05	CcSEcCtD
Aripiprazole—Dyspnoea—Lisinopril—coronary artery disease	1.62e-05	8.94e-05	CcSEcCtD
Aripiprazole—Rash—Captopril—coronary artery disease	1.62e-05	8.93e-05	CcSEcCtD
Aripiprazole—Dermatitis—Captopril—coronary artery disease	1.62e-05	8.92e-05	CcSEcCtD
Aripiprazole—Somnolence—Lisinopril—coronary artery disease	1.62e-05	8.91e-05	CcSEcCtD
Aripiprazole—Feeling abnormal—Timolol—coronary artery disease	1.62e-05	8.91e-05	CcSEcCtD
Aripiprazole—Headache—Captopril—coronary artery disease	1.61e-05	8.87e-05	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Timolol—coronary artery disease	1.6e-05	8.84e-05	CcSEcCtD
Aripiprazole—Dizziness—Furosemide—coronary artery disease	1.6e-05	8.84e-05	CcSEcCtD
Aripiprazole—Dyspepsia—Lisinopril—coronary artery disease	1.6e-05	8.83e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Losartan—coronary artery disease	1.6e-05	8.82e-05	CcSEcCtD
Aripiprazole—Nausea—Trandolapril—coronary artery disease	1.6e-05	8.8e-05	CcSEcCtD
Aripiprazole—Urticaria—Ramipril—coronary artery disease	1.59e-05	8.78e-05	CcSEcCtD
Aripiprazole—Nausea—Enalapril—coronary artery disease	1.59e-05	8.77e-05	CcSEcCtD
Aripiprazole—Vomiting—Perindopril—coronary artery disease	1.59e-05	8.74e-05	CcSEcCtD
Aripiprazole—Body temperature increased—Ramipril—coronary artery disease	1.59e-05	8.74e-05	CcSEcCtD
Aripiprazole—Abdominal pain—Ramipril—coronary artery disease	1.59e-05	8.74e-05	CcSEcCtD
Aripiprazole—Decreased appetite—Lisinopril—coronary artery disease	1.58e-05	8.72e-05	CcSEcCtD
Aripiprazole—Rash—Perindopril—coronary artery disease	1.57e-05	8.67e-05	CcSEcCtD
Aripiprazole—Dermatitis—Perindopril—coronary artery disease	1.57e-05	8.66e-05	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.57e-05	8.66e-05	CcSEcCtD
Aripiprazole—Nausea—Telmisartan—coronary artery disease	1.57e-05	8.65e-05	CcSEcCtD
Aripiprazole—Fatigue—Lisinopril—coronary artery disease	1.57e-05	8.64e-05	CcSEcCtD
Aripiprazole—Headache—Perindopril—coronary artery disease	1.56e-05	8.61e-05	CcSEcCtD
Aripiprazole—Urticaria—Timolol—coronary artery disease	1.56e-05	8.59e-05	CcSEcCtD
Aripiprazole—Pain—Lisinopril—coronary artery disease	1.56e-05	8.57e-05	CcSEcCtD
Aripiprazole—Constipation—Lisinopril—coronary artery disease	1.56e-05	8.57e-05	CcSEcCtD
Aripiprazole—Body temperature increased—Timolol—coronary artery disease	1.55e-05	8.54e-05	CcSEcCtD
Aripiprazole—Abdominal pain—Timolol—coronary artery disease	1.55e-05	8.54e-05	CcSEcCtD
Aripiprazole—Dizziness—Losartan—coronary artery disease	1.55e-05	8.53e-05	CcSEcCtD
Aripiprazole—Vomiting—Furosemide—coronary artery disease	1.54e-05	8.5e-05	CcSEcCtD
Aripiprazole—Rash—Furosemide—coronary artery disease	1.53e-05	8.43e-05	CcSEcCtD
Aripiprazole—Dermatitis—Furosemide—coronary artery disease	1.53e-05	8.42e-05	CcSEcCtD
Aripiprazole—Nausea—Captopril—coronary artery disease	1.53e-05	8.41e-05	CcSEcCtD
Aripiprazole—Headache—Furosemide—coronary artery disease	1.52e-05	8.37e-05	CcSEcCtD
Aripiprazole—Feeling abnormal—Lisinopril—coronary artery disease	1.5e-05	8.26e-05	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Lisinopril—coronary artery disease	1.49e-05	8.2e-05	CcSEcCtD
Aripiprazole—Vomiting—Losartan—coronary artery disease	1.49e-05	8.2e-05	CcSEcCtD
Aripiprazole—Nausea—Perindopril—coronary artery disease	1.48e-05	8.17e-05	CcSEcCtD
Aripiprazole—Hypersensitivity—Ramipril—coronary artery disease	1.48e-05	8.15e-05	CcSEcCtD
Aripiprazole—Rash—Losartan—coronary artery disease	1.48e-05	8.13e-05	CcSEcCtD
Aripiprazole—Dermatitis—Losartan—coronary artery disease	1.47e-05	8.12e-05	CcSEcCtD
Aripiprazole—Headache—Losartan—coronary artery disease	1.47e-05	8.08e-05	CcSEcCtD
Aripiprazole—Urticaria—Lisinopril—coronary artery disease	1.45e-05	7.97e-05	CcSEcCtD
Aripiprazole—Hypersensitivity—Timolol—coronary artery disease	1.45e-05	7.96e-05	CcSEcCtD
Aripiprazole—Nausea—Furosemide—coronary artery disease	1.44e-05	7.94e-05	CcSEcCtD
Aripiprazole—Asthenia—Ramipril—coronary artery disease	1.44e-05	7.93e-05	CcSEcCtD
Aripiprazole—Body temperature increased—Lisinopril—coronary artery disease	1.44e-05	7.93e-05	CcSEcCtD
Aripiprazole—Abdominal pain—Lisinopril—coronary artery disease	1.44e-05	7.93e-05	CcSEcCtD
Aripiprazole—Pruritus—Ramipril—coronary artery disease	1.42e-05	7.82e-05	CcSEcCtD
Aripiprazole—Asthenia—Timolol—coronary artery disease	1.41e-05	7.75e-05	CcSEcCtD
Aripiprazole—Nausea—Losartan—coronary artery disease	1.39e-05	7.66e-05	CcSEcCtD
Aripiprazole—Pruritus—Timolol—coronary artery disease	1.39e-05	7.65e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Ramipril—coronary artery disease	1.37e-05	7.56e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Timolol—coronary artery disease	1.34e-05	7.39e-05	CcSEcCtD
Aripiprazole—Hypersensitivity—Lisinopril—coronary artery disease	1.34e-05	7.39e-05	CcSEcCtD
Aripiprazole—Dizziness—Ramipril—coronary artery disease	1.33e-05	7.31e-05	CcSEcCtD
Aripiprazole—Asthenia—Lisinopril—coronary artery disease	1.31e-05	7.19e-05	CcSEcCtD
Aripiprazole—Dizziness—Timolol—coronary artery disease	1.3e-05	7.15e-05	CcSEcCtD
Aripiprazole—Pruritus—Lisinopril—coronary artery disease	1.29e-05	7.09e-05	CcSEcCtD
Aripiprazole—Vomiting—Ramipril—coronary artery disease	1.28e-05	7.03e-05	CcSEcCtD
Aripiprazole—Rash—Ramipril—coronary artery disease	1.27e-05	6.97e-05	CcSEcCtD
Aripiprazole—Dermatitis—Ramipril—coronary artery disease	1.26e-05	6.96e-05	CcSEcCtD
Aripiprazole—Headache—Ramipril—coronary artery disease	1.26e-05	6.93e-05	CcSEcCtD
Aripiprazole—Vomiting—Timolol—coronary artery disease	1.25e-05	6.87e-05	CcSEcCtD
Aripiprazole—Diarrhoea—Lisinopril—coronary artery disease	1.25e-05	6.86e-05	CcSEcCtD
Aripiprazole—Rash—Timolol—coronary artery disease	1.24e-05	6.81e-05	CcSEcCtD
Aripiprazole—Dermatitis—Timolol—coronary artery disease	1.24e-05	6.81e-05	CcSEcCtD
Aripiprazole—Headache—Timolol—coronary artery disease	1.23e-05	6.77e-05	CcSEcCtD
Aripiprazole—Dizziness—Lisinopril—coronary artery disease	1.2e-05	6.63e-05	CcSEcCtD
Aripiprazole—Nausea—Ramipril—coronary artery disease	1.19e-05	6.57e-05	CcSEcCtD
Aripiprazole—Nausea—Timolol—coronary artery disease	1.17e-05	6.42e-05	CcSEcCtD
Aripiprazole—Vomiting—Lisinopril—coronary artery disease	1.16e-05	6.37e-05	CcSEcCtD
Aripiprazole—Rash—Lisinopril—coronary artery disease	1.15e-05	6.32e-05	CcSEcCtD
Aripiprazole—Dermatitis—Lisinopril—coronary artery disease	1.15e-05	6.32e-05	CcSEcCtD
Aripiprazole—Headache—Lisinopril—coronary artery disease	1.14e-05	6.28e-05	CcSEcCtD
Aripiprazole—Nausea—Lisinopril—coronary artery disease	1.08e-05	5.96e-05	CcSEcCtD
Aripiprazole—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	7.05e-07	5.85e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	7.05e-07	5.84e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	7.03e-07	5.83e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ABCA1—coronary artery disease	7.03e-07	5.82e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CASP3—coronary artery disease	6.99e-07	5.79e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APOA1—coronary artery disease	6.99e-07	5.79e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	6.99e-07	5.79e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TGFB1—coronary artery disease	6.98e-07	5.78e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—AKT1—coronary artery disease	6.97e-07	5.78e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—PIK3CA—coronary artery disease	6.97e-07	5.77e-06	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—AKT1—coronary artery disease	6.96e-07	5.76e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—coronary artery disease	6.94e-07	5.76e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MMP9—coronary artery disease	6.94e-07	5.75e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CCND1—coronary artery disease	6.91e-07	5.73e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	6.91e-07	5.73e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MMP9—coronary artery disease	6.9e-07	5.72e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	6.89e-07	5.71e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MAPK1—coronary artery disease	6.84e-07	5.67e-06	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTGS2—coronary artery disease	6.81e-07	5.64e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GGT1—coronary artery disease	6.8e-07	5.64e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GOT1—coronary artery disease	6.8e-07	5.64e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CCND1—coronary artery disease	6.8e-07	5.64e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	6.8e-07	5.63e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CXCL8—coronary artery disease	6.73e-07	5.58e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	6.73e-07	5.58e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MMP9—coronary artery disease	6.71e-07	5.56e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	6.69e-07	5.55e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TGFB1—coronary artery disease	6.65e-07	5.51e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	6.63e-07	5.49e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CXCL8—coronary artery disease	6.61e-07	5.48e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MMP9—coronary artery disease	6.61e-07	5.47e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	6.6e-07	5.47e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	6.59e-07	5.46e-06	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	6.57e-07	5.45e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	6.57e-07	5.44e-06	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	6.56e-07	5.44e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TGFB1—coronary artery disease	6.56e-07	5.44e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PPARG—coronary artery disease	6.53e-07	5.41e-06	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—PIK3CA—coronary artery disease	6.52e-07	5.41e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MAPK1—coronary artery disease	6.52e-07	5.4e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	6.51e-07	5.4e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—AKT1—coronary artery disease	6.51e-07	5.4e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	6.51e-07	5.39e-06	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	6.5e-07	5.39e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CXCL8—coronary artery disease	6.49e-07	5.38e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	6.47e-07	5.36e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—coronary artery disease	6.45e-07	5.35e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CASP3—coronary artery disease	6.44e-07	5.34e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—POMC—coronary artery disease	6.44e-07	5.34e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MAPK1—coronary artery disease	6.43e-07	5.33e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—AKT1—coronary artery disease	6.41e-07	5.31e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—coronary artery disease	6.4e-07	5.31e-06	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	6.4e-07	5.3e-06	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	6.39e-07	5.29e-06	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	6.39e-07	5.29e-06	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	6.37e-07	5.28e-06	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	6.35e-07	5.26e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CASP3—coronary artery disease	6.34e-07	5.26e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CASP3—coronary artery disease	6.33e-07	5.24e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CASP3—coronary artery disease	6.31e-07	5.23e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—coronary artery disease	6.3e-07	5.22e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CASP3—coronary artery disease	6.29e-07	5.21e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—coronary artery disease	6.29e-07	5.21e-06	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—PIK3CA—coronary artery disease	6.28e-07	5.21e-06	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	6.28e-07	5.21e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CCND1—coronary artery disease	6.27e-07	5.2e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—AKT1—coronary artery disease	6.27e-07	5.19e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—coronary artery disease	6.27e-07	5.19e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—coronary artery disease	6.25e-07	5.18e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	6.23e-07	5.16e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CASP3—coronary artery disease	6.23e-07	5.16e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CASP3—coronary artery disease	6.21e-07	5.15e-06	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—PIK3CA—coronary artery disease	6.2e-07	5.14e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	6.2e-07	5.14e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—coronary artery disease	6.19e-07	5.13e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CCND1—coronary artery disease	6.17e-07	5.12e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—coronary artery disease	6.17e-07	5.11e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CCND1—coronary artery disease	6.16e-07	5.1e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PPARG—coronary artery disease	6.16e-07	5.1e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CCND1—coronary artery disease	6.14e-07	5.09e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CCND1—coronary artery disease	6.12e-07	5.07e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTP1—coronary artery disease	6.11e-07	5.07e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MMP9—coronary artery disease	6.09e-07	5.05e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—POMC—coronary artery disease	6.07e-07	5.03e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CCND1—coronary artery disease	6.06e-07	5.02e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	6.06e-07	5.02e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CCND1—coronary artery disease	6.04e-07	5.01e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—HMOX1—coronary artery disease	6.03e-07	5e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	6.03e-07	5e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—coronary artery disease	6.03e-07	5e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	6e-07	4.97e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MMP9—coronary artery disease	5.99e-07	4.97e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MMP9—coronary artery disease	5.98e-07	4.96e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	5.98e-07	4.95e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MMP9—coronary artery disease	5.96e-07	4.94e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CAT—coronary artery disease	5.95e-07	4.93e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MMP9—coronary artery disease	5.94e-07	4.92e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—PIK3CA—coronary artery disease	5.94e-07	4.92e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—coronary artery disease	5.93e-07	4.92e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TGFB1—coronary artery disease	5.92e-07	4.91e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—AKT1—coronary artery disease	5.91e-07	4.9e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MMP9—coronary artery disease	5.88e-07	4.88e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ALB—coronary artery disease	5.87e-07	4.87e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MMP9—coronary artery disease	5.87e-07	4.86e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	5.86e-07	4.86e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	5.82e-07	4.83e-06	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—coronary artery disease	5.82e-07	4.82e-06	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—coronary artery disease	5.81e-07	4.82e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	5.81e-07	4.82e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MAPK1—coronary artery disease	5.81e-07	4.81e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—AKT1—coronary artery disease	5.8e-07	4.81e-06	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—PIK3CA—coronary artery disease	5.8e-07	4.8e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	5.78e-07	4.79e-06	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—coronary artery disease	5.78e-07	4.79e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOB—coronary artery disease	5.77e-07	4.79e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	5.77e-07	4.78e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	5.76e-07	4.78e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	5.73e-07	4.75e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	5.72e-07	4.74e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	5.71e-07	4.73e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—AKT1—coronary artery disease	5.69e-07	4.72e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	5.69e-07	4.71e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	5.66e-07	4.69e-06	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—coronary artery disease	5.66e-07	4.69e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—PIK3CA—coronary artery disease	5.63e-07	4.67e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—NOS3—coronary artery disease	5.62e-07	4.66e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTM1—coronary artery disease	5.62e-07	4.66e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	5.62e-07	4.65e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	5.61e-07	4.65e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—PIK3CA—coronary artery disease	5.58e-07	4.63e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	5.58e-07	4.62e-06	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—coronary artery disease	5.56e-07	4.61e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ALB—coronary artery disease	5.54e-07	4.59e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TGFB1—coronary artery disease	5.53e-07	4.58e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—LPL—coronary artery disease	5.51e-07	4.57e-06	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—coronary artery disease	5.49e-07	4.55e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—coronary artery disease	5.47e-07	4.53e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	5.45e-07	4.52e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TGFB1—coronary artery disease	5.44e-07	4.51e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK1—coronary artery disease	5.42e-07	4.5e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	5.38e-07	4.46e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GPX1—coronary artery disease	5.38e-07	4.46e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—coronary artery disease	5.37e-07	4.45e-06	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—AKT1—coronary artery disease	5.37e-07	4.45e-06	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—AKT1—coronary artery disease	5.36e-07	4.44e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	5.35e-07	4.44e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK1—coronary artery disease	5.34e-07	4.43e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	5.34e-07	4.42e-06	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—AKT1—coronary artery disease	5.33e-07	4.42e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—coronary artery disease	5.31e-07	4.4e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—NOS3—coronary artery disease	5.3e-07	4.39e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	5.29e-07	4.38e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	5.28e-07	4.38e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—coronary artery disease	5.27e-07	4.37e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—coronary artery disease	5.26e-07	4.36e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CD36—coronary artery disease	5.24e-07	4.34e-06	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—AKT1—coronary artery disease	5.22e-07	4.32e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPP2CA—coronary artery disease	5.17e-07	4.29e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—coronary artery disease	5.14e-07	4.26e-06	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—AKT1—coronary artery disease	5.13e-07	4.25e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	5.09e-07	4.22e-06	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—AKT1—coronary artery disease	5.06e-07	4.2e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—PIK3CA—coronary artery disease	5.04e-07	4.18e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TGFB1—coronary artery disease	5.02e-07	4.16e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—coronary artery disease	5.01e-07	4.15e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PIK3CA—coronary artery disease	4.98e-07	4.13e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.96e-07	4.11e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—coronary artery disease	4.94e-07	4.1e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	4.94e-07	4.09e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TGFB1—coronary artery disease	4.93e-07	4.08e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK1—coronary artery disease	4.92e-07	4.08e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	4.91e-07	4.07e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—AKT1—coronary artery disease	4.9e-07	4.06e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	4.9e-07	4.06e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	4.9e-07	4.06e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	4.86e-07	4.03e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—AKT1—coronary artery disease	4.85e-07	4.02e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	4.85e-07	4.02e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	4.84e-07	4.01e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—coronary artery disease	4.84e-07	4.01e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	4.84e-07	4.01e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TGFB1—coronary artery disease	4.84e-07	4.01e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK1—coronary artery disease	4.83e-07	4.01e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	4.82e-07	3.99e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	4.8e-07	3.98e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	4.76e-07	3.94e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK1—coronary artery disease	4.74e-07	3.93e-06	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—AKT1—coronary artery disease	4.74e-07	3.92e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AGT—coronary artery disease	4.72e-07	3.91e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—PIK3CA—coronary artery disease	4.71e-07	3.9e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PIK3CA—coronary artery disease	4.63e-07	3.84e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—AKT1—coronary artery disease	4.62e-07	3.83e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOE—coronary artery disease	4.62e-07	3.83e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—AKT1—coronary artery disease	4.6e-07	3.81e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PIK3CA—coronary artery disease	4.57e-07	3.79e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOA1—coronary artery disease	4.57e-07	3.79e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—AKT1—coronary artery disease	4.56e-07	3.78e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—coronary artery disease	4.5e-07	3.73e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	4.49e-07	3.72e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—coronary artery disease	4.46e-07	3.7e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	4.41e-07	3.65e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—coronary artery disease	4.31e-07	3.57e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—coronary artery disease	4.29e-07	3.55e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	4.27e-07	3.54e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	4.2e-07	3.48e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	4.19e-07	3.48e-06	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PIK3CA—coronary artery disease	4.19e-07	3.47e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	4.18e-07	3.46e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—coronary artery disease	4.17e-07	3.45e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	4.17e-07	3.45e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—AKT1—coronary artery disease	4.15e-07	3.44e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	4.13e-07	3.42e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—AKT1—coronary artery disease	4.12e-07	3.41e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PIK3CA—coronary artery disease	4.12e-07	3.41e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—coronary artery disease	4.1e-07	3.4e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AKT1—coronary artery disease	4.07e-07	3.37e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARG—coronary artery disease	4.03e-07	3.34e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AKT1—coronary artery disease	3.97e-07	3.29e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—POMC—coronary artery disease	3.97e-07	3.29e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AKT1—coronary artery disease	3.95e-07	3.28e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AKT1—coronary artery disease	3.85e-07	3.19e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	3.82e-07	3.17e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AKT1—coronary artery disease	3.78e-07	3.14e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—coronary artery disease	3.78e-07	3.13e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AKT1—coronary artery disease	3.74e-07	3.1e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—coronary artery disease	3.72e-07	3.08e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—coronary artery disease	3.71e-07	3.08e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—coronary artery disease	3.7e-07	3.07e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—coronary artery disease	3.69e-07	3.06e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—coronary artery disease	3.65e-07	3.03e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—coronary artery disease	3.64e-07	3.02e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ALB—coronary artery disease	3.62e-07	3e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AKT1—coronary artery disease	3.49e-07	2.89e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NOS3—coronary artery disease	3.46e-07	2.87e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AKT1—coronary artery disease	3.43e-07	2.85e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AKT1—coronary artery disease	3.43e-07	2.84e-06	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AKT1—coronary artery disease	3.42e-07	2.84e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AKT1—coronary artery disease	3.41e-07	2.83e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AKT1—coronary artery disease	3.4e-07	2.82e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—coronary artery disease	3.39e-07	2.81e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AKT1—coronary artery disease	3.37e-07	2.79e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AKT1—coronary artery disease	3.36e-07	2.79e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.17e-07	2.62e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PIK3CA—coronary artery disease	3.16e-07	2.62e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	3.12e-07	2.59e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.98e-07	2.47e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AKT1—coronary artery disease	2.58e-07	2.14e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AKT1—coronary artery disease	2.43e-07	2.02e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.95e-07	1.61e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AKT1—coronary artery disease	1.59e-07	1.32e-06	CbGpPWpGaD
